Adagene First Half 2024 Earnings: US$0.39 loss per share (vs US$0.094 loss in 1H 2023)

The company reported a net loss of US$17.0m, widening by 314% from the previous period, with a loss per share of US$0.39. Revenue is forecasted to grow 55% annually for the next 3 years, outperforming the industry average.